Description
Participants will review the underlying pathophysiology of drug-induced movement disorders commonly associated with antipsychotic and other dopamine-modifying therapies. The primary focus will be on the clinical presentation of common movement disorder subtypes, ensuring learners can accurately distinguish between conditions like acute dystonia, akathisia, drug-induced parkinsonism, and tardive dyskinesia. This session provides the essential knowledge base for all clinicians.
Join Seeing Beyond the Shake: Drug-Induced Movement Disorders Interactive Case Application on January 20 at 12-1 PM (PT) to practice your skills detecting, assessing, documenting and monitoring these disorders.
Format
Live webinar with question and answer period.
Learning Objectives
At the completion of the activity, participants will:
- Describe the pathophysiology and mechanisms underlying common drug-induced movement disorders associated with dopamine-modifying therapies.
- Differentiate among the clinical characteristics of acute dystonia, akathisia, drug-induced parkinsonism, and tardive dyskinesia.
- Apply evidence-based approaches to the assessment and treatment of drug-induced movement disorders using validated rating scales and guideline-supported interventions.
Outline
- Pathophysiology and Subtype Differentiation: Review the underlying mechanisms and distinct clinical features of the four common drug-induced movement disorder (DIMD) subtypes: acute dystonia, akathisia, drug-induced parkinsonism, and tardive dyskinesia.
- Structured Assessment: Learn how to apply evidence-based, validated rating scales and structured assessment tools for the practical detection and monitoring of DIMDs in clinical practice.
- Optimizing Patient Management: Strengthen the ability to accurately identify, document, and communicate DIMD findings to optimize patient care, implement guideline-supported interventions, and ensure medication safety.
Target Audience
Psychiatrist, Resident or Fellow, Medical Student, Physician (Non-Psychiatric), Physician Assistant, Nurse, Nurse Practitioner, Psychiatric Technician, Pharmacist
Instructional Level
Intermediate
Estimated Time to Complete
Estimated Duration: 1 hour
Program Release Date: January 13, 2026
Program End Date: January 13, 2026
Ongoing Interdisciplinary Discussion Board
After completing the course, engage with colleagues in the mental health field through the Webinar Roundtable Topics discussion board. This is an easy way to network and share ideas with other clinicians who participate in this webinar. Access through the discussion tab.
How to Earn Credit
After completing the evaluation, participants will have the opportunity to claim their hours of participation and download the appropriate certificate. Physicians may obtain an official CME certificate, other healthcare professionals may receive a CE certificate (as applicable), and all other attendees may generate a certificate of participation. Each certificate will reflect the event date and total hours earned.
Continuing Education Credit
In support of improving patient care, American Psychiatric Association (APA) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
The APA designates this live event for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses/Nurse Practitioners
The American Psychiatric Association (APA) designates this activity for 1.00 Nursing contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.
Psychiatric Technicians
The American Psychiatric Association (APA) is approved by the California Board of Vocational Nursing and Psychiatric Technicians (BVNPT) as a provider of continuing education for Licensed Psychiatric Technicians (LPTs). Provider Number: 15028
This course is approved for 1.00 of continuing education for LPTs.
Pharmacists
This curriculum has been approved for 1.00 contact hours by the American Psychiatric Association. The American Psychiatric Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The Universal Activity Number for this program is JA0000145-0000-26-002-L05-P. This learning activity is knowledge based. Your CE credits will be electronically submitted to NABP upon successful completion of the activity. Pharmacists with questions can contact NABP customer service (custserv@nabp.net).
Psychologists
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
***Continuing education requirements vary from state to state. Many state boards grant reciprocity with national accrediting organizations and other state boards. It is the responsibility of each professional to understand the requirements for license renewal or check with the state or national licensing board and/or professional organization to become more familiar with their policies for acceptable continuing education credit. Social workers and Psychologists should contact their regulatory board to determine course approval.
Faculty and Planner Disclosures
The American Psychiatric Association adheres to the ACCME's Standards for Integrity and Independence in Accredited Medical Education. Any individuals in a position to control the content of a CME activity - including faculty, planners, reviewers, or others - are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Faculty:
Austin Campbell, PharmD, is a Clinical Associate Professor at the University of Missouri–Kansas City School of Pharmacy and an Adjunct Assistant Professor at the University of Missouri School of Medicine. He is a Board-Certified Psychiatric Pharmacist (BCPP) and Fellow of the American Association of Psychiatric Pharmacists (FAAPP), with more than 15 years of experience teaching psychopharmacology to students, residents, and fellows across multiple disciplines. For over a decade, he served as an inpatient Clinical Pharmacy Specialist in Psychiatry at the Missouri Psychiatric Center before transitioning to academia in 2022. Since that time, he has practiced as a psychiatric ambulatory care pharmacist within an internal medicine clinic. He is widely published in peer-reviewed journals, has authored multiple book chapters on psychiatric treatment, and is a frequent speaker at national and state conferences. His contributions have been recognized with numerous honors, including Teacher of the Year in 2024 and 2025, Pharmacist of the Year from the Missouri Society of Health-System Pharmacists (MSHP) in 2025, and election to the American Association of Psychiatric Pharmacists Board of Directors as Member-at-Large beginning in 2026. Dr. Campbell has no relevant financial relationships to disclose.
Steven Stoner, PharmD, BCPP, FAAPP, is a Clinical Professor and the Associate Dean for Student Affairs, while previously serving as the Department Chair of the Division of Pharmacy Practice and Administration at the UMKC School of Pharmacy. Dr. Stoner served as the director of an ASHP accredited psychiatric Pharmacy Practice residency program for 10 years (1998-2008) at the Northwest Missouri Psychiatric Rehabilitation Center in St. Joseph, Missouri. In 2006, he completed the American Association of Colleges of Pharmacy Academic (AACP) Leadership Fellows Program. Dr. Stoner is also a member of the American Association of Colleges of Pharmacy and has served on several committees as well as serving on the AACP Board of Directors (2016-2019), as the Chair of the Council of Sections (2017-2018), and the Chair of the Pharmacy Practice Section (2014-2015). Dr. Stoner was also the 2024 recipient of the Anne Marie Liles Distinguished Service Award from AACP and was recently named a Fellow of the American Association of Psychiatric Pharmacists. Dr. Stoner has no relevant financial relationships to disclose.
Program Planners:
- John Torous, MD, Beth Israel Deaconess Medical Center. Dr. Torous has no relevant financial relationships to disclose.
- Kathryn Hanley, APRN, Austin State Hospital. Ms. Hanley has no relevant financial relationships to disclose.
- Megan Ehret, PharmD, BCPP, University of Maryland, Baltimore. Dr. Ehret has no relevant financial relationships to disclose.
- Amy N. Cohen, PhD, American Psychiatric Association. Reports no financial relationships with commercial interests.
- Charles Purdue, California Department of State Hospitals. Mr. Purdue reports no financial relationships with commercial interests.
Accessibility for Participants with Disabilities
The American Psychiatric Association is committed to ensuring accessibility of its website to people with disabilities. If you have trouble accessing any of APA’s online resources, please contact us at 202-559-3900 for assistance.
Technical Requirements
This internet-based CME activity is best experienced using any of the following:
The latest and 2nd latest public versions of Google Chrome, Mozilla Firefox, or Safari
Internet Explorer 11+
This Web site requires JavaScript and session cookies to be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be Adobe Acrobat Reader, Microsoft PowerPoint, or Windows Media Player.
Optimal System Configuration:
Browser: Google Chrome (latest and 2nd latest version), Safari (latest and 2nd latest version), Internet Explorer 11.0+, Firefox (latest and 2nd latest version), or Microsoft Edge (latest and 2nd latest version)
Operating System: Windows versions 8.1+, Mac OS X 10.5 (Leopard) +, Android (latest and 2nd latest version), or iOS/iPad OS (latest and 2nd latest version)
Internet Connection: 1 Mbps or higher
Minimum Requirements:
Windows PC:
Windows 8.1 or higher; 1 GB (for 32-bit)/2 GB (for 64-bit) or higher RAM; Microsoft DirectX 9 graphics device with WDDM driver; audio playback with speakers for programs with video
For assistance: Contact educme@psych.org for questions about this activity |
Contact support@smicaladviser.org for technical assistance